World · English
China rushes to develop Moderna-style cancer vaccines amid market frenzy
China is accelerating development of cancer vaccines similar to Moderna's, following a surge in stock prices of Hong Kong-listed biotech companies after Moderna's breakthrough trial. These companies, including Jiangsu Hengrui Pharmaceuticals and CK Life Sciences, have multiple cancer vaccines in development.
Read the full report at SCMP News →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.